- Main
Symptoms of Anxiety, Burnout, and PTSD and the Mitigation Effect of Serologic Testing in Emergency Department Personnel During the COVID-19 Pandemic
- Rodriguez, Robert M;
- Montoy, Juan Carlos C;
- Hoth, Karin F;
- Talan, David A;
- Harland, Karisa K;
- Eyck, Patrick Ten;
- Mower, William;
- Krishnadasan, Anusha;
- Santibanez, Scott;
- Mohr, Nicholas;
- Network, Project COVERED Emergency Department;
- Bahamon, Monica;
- Carlson, Jestin N;
- Chisolm-Straker, Makini;
- Driver, Brian;
- Faine, Brett;
- Pharm, D;
- Galbraith, James;
- Giordano, Philip A;
- Haran, John P;
- Higgins, Amanda;
- Hinson, Jeremiah;
- House, Stacey;
- Idris, Ahamed H;
- Kean, Efrat;
- Krebs, Elizabeth;
- Kurz, Michael C;
- Lee, Lilly;
- Liang, Stephen Y;
- Lim, Stephen C;
- Moran, Gregory;
- Nandi, Utsav;
- Pathmarajah, Kavitha;
- Paxton, James H;
- Perez, Yesenia;
- Rothman, Richard;
- Schrading, Walter A;
- Shuck, Jessica;
- Slev, Patricia;
- Smithline, Howard A;
- Souffront, Kimberly;
- Steele, Mark;
- St. Romain, Michelle;
- Stubbs, Amy;
- Swanson, Morgan;
- Tiao, Josh;
- Torres, Jesus R;
- Trent, Stacy;
- Uribe, Lisandra;
- Venkat, Arvind;
- Volturo, Gregory;
- Wallace, Kelli;
- Weber, Kurt D
Published Web Location
https://doi.org/10.1016/j.annemergmed.2021.01.028Abstract
STUDY OBJECTIVE: Among a comprehensive range of frontline emergency department health care personnel, we assessed symptoms of anxiety and burnout, specific coronavirus disease 2019 (COVID-19) work-related stressors, and risk for post-traumatic stress disorder (PTSD). We also determined whether COVID-19 serologic testing of HCP decreased their self-reported anxiety. METHODS: In a prospective cohort study from May 13, 2020, to July 8, 2020, we used electronic surveys to capture participant self-reported symptoms before and after serologic testing for anti-SARS-CoV-2 immunoglobulin G antibodies. Participants were physicians, nurses, advanced practice providers, and nonclinical ED personnel at 20 geographically diverse United States EDs. We evaluated these domains: 1) the effects of the COVID-19 pandemic on overall stress and anxiety; 2) COVID-19-related work stressors; 3) burnout; and 4) PTSD risk (measured using the Primary Care-PTSD Screen for DSM-5, a 5-item screening instrument in which a score of ≥3 signifies high risk for PTSD). We also assessed perceptions of whether results of COVID-19 antibody testing decreased participants' self-reported anxiety. RESULTS: Of 1,606 participants, 100% and 88% responded to the baseline and follow-up surveys, respectively. At baseline, approximately half (46%) reported symptoms of emotional exhaustion and burnout from their work, and 308 (19.2%, 95% confidence interval [CI] 17.3% to 21.1%) respondents screened positive for increased PTSD risk. Female respondents were more likely than males to screen positive (odds ratio [OR] 2.03, 95% CI 1.49 to 2.78). Common concerns included exposing their family and the health of coworkers diagnosed with COVID-19. After receiving antibody test results, 54% (95% CI 51.8 to 56.7) somewhat agreed, agreed, or strongly agreed that knowledge of their immune status had decreased their anxiety. A positive serology result indicating prior SARS-CoV-2 infection was associated with a higher likelihood of reporting decreased anxiety (2.83, 95% CI 1.37 to 5.83). CONCLUSION: Symptoms of anxiety and burnout were prevalent across the spectrum of ED staff during the COVID-19 pandemic. One-fifth of ED personnel appeared to be at risk for PTSD. Increased provision of serologic testing may help to mitigate anxiety.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.